Shares rose more than 10% in morning trading, and the stock has tripled in value year to date. FMTNews Covid19
MADRID: Spanish pharmaceutical company PharmaMar said on Friday a clinical trial of its cancer drug Aplidin to treat adult patients with Covid-19 was successful and it now aims to start phase III trials.
PharmaMar shares rose more than 10% in morning trading, outperforming the Ibex-35. Year to date, the stock has more than tripled in value, Refinitiv Eikon data shows. The company said there was a substantial reduction in viral load and the C-reactive protein in patients, and that 80.7% of patients had been discharged before the 15th day of hospitalisation, and 38.2% before the eighth day.
“With these data, the company will begin, in the next few days, conversations with the regulatory agencies to define the next phase III pivotal study for plitidepsin in patients with Covid-19, who require hospitalisation,” PharmaMar said in a statement. Meanwhile, Spanish Agency for Medicines and Healthcare Products has given the company the green light to increase the number of patients being treated with Aplidin in hospitals, following results obtained from the first group of patients.PharmaMar, which investigates and develops marine molecules to treat tumours, will give more details on the results during a news conference on Monday.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bekas pesakit Covid-19 mohon tampil bantu kajianKuala Lumpur: Bekas pesakit Covid-19 diperlukan bagi membantu kajian mengenai tindak balas antibodi neutralisasi dalam kalangan pesakit Covid-19 di Malaysia, kata Ketua Pengarah Kesihatan Tan Sri Dr Noor Hisham Abdullah.
Read more »
Covid-19 recovery: Singapore MPs call for more digital economic plans, govt aid, mental health awareness | Malay MailSINGAPORE, Oct 15 — Life may be slowly returning to normal, several Members of Parliament (MPs) noted yester, but the next round of Singapore’s pandemic response will require critical steps for the country to thrive in the new digital economy. It will also require its workforce to raise their...
Read more »
MBJB orders temporary closure of night, morning marketsCOVID-19 | The Johor Bahru City Council says the closure is to prevent the spread of Covid-19.
Read more »
Remdesivir has 'little or no effect' on Covid-19 mortality: WHO study | New Straits TimesNSTworld The antiviral drug remdesivir, considered one of the most promising Covid19 treatments, turns out to do little to prevent deaths from the disease, according to a WHO-backed study. coronavirus
Read more »